<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210510051249N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-08-25</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of counseling  on perceived  stress, number of ‎oocytes retrieved and pregnancy rates</public_title>
      <acronym>ACT</acronym>
      <scientific_title>The effect of counseling based on acceptance and commitment  consulting on perceived  stress, number of ‎oocytes retrieved and pregnancy rates in infertile women undergoing IVF treatments</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-09-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>76</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56360</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Sampling is available by simple random assignment. After determining the sample size, through a table of random numbers using the statistical software  Random allocation software, the numbers are divided into two groups of sequences marked with the letters A and B. The sequence stored in sealed envelopes that the researcher uses when selecting a research unit to send individuals to two groups that meet the inclusion criteria.</study_design>
      <phase>N/A</phase>
      <hc_freetext>The effect of counseling based on acceptance and commitment  consulting on perceived  stress number of ‎oocytes retrieved and pregnancy rates in infertile women undergoing IVF treatments.</hc_freetext>
      <i_freetext>Intervention 1: The intervention group will receive six sessions of 45-60 minutes, counseling based on acceptance and commitment individually, the first session of day 2 to 3 of the first cycle (after basic ultrasound) in person and the rest of the sessions in absentia every six days ( Day 8- 14-20-26 The first cycle and the last session will be run on days 2 to 3 of the next virtual cycle. Intervention 2: Control group: In the first session, the control group completes the questionnaires and provides the routine services of the center, which include explanations about IVF treatment and possible complications and costs for treatment, to decide on treatment. On day 2-3 of the cycle, measures including basic ultrasound and initial tests are requested and then 21 units of subcutaneous ampoules of Cinnafact are prescribed daily for 0.5 units, and they are taught how to use infertility drugs and the time of their next visit. Second, HMG 150-300 units are added daily depending on the ovarian reserve under the supervision of an infertility specialist and 6 days after the onset of ovarian stimulation, folliculography is performed every two to three days, until at least 3 dominant 17 mm follicles are observed. HCG is triggered and ovulation will occur 36 hours later.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Toktam taheri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University Street, Ph.D. Crossroads, School of Nursing and Midwifery</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9189835486</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>taherits971@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nahid Jahani Shorab</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Ibn Sina St., Doctora Intersection, Daneshgah St., Mashhad, Khorasan Razavi, Iran</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>jahanishn@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of primary infertility, Iranian and resident of Mashhad, ability to speak and write in Persian, no known medical diseases, age between 20 to 40 years, couple have no children or adopted children, no mental illness, IVF treatment for For the first time, in the basic ultrasound (day 2 to 3 of the cycle) the ovary has a normal appearance to start treatment, the spermogram is normal, the husband has no other spouse, no smoking and alcohol consumption, BMI is below 30, IVF candidate, has Smartphone and consent to participate in the study</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Intend to use embryos and donated eggs or surrogates</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The intervention group will receive six sessions of 45-60 minutes, counseling based on acceptance and commitment individually, the first session of day 2 to 3 of the first cycle (after basic ultrasound) in person and the rest of the sessions in absentia every six days ( Day 8- 14-20-26 The first cycle and the last session will be run on days 2 to 3 of the next virtual cycle</i_keyword>
      <i_keyword>Control group: In the first session, the control group completes the questionnaires and provides the routine services of the center, which include explanations about IVF treatment and possible complications and costs for treatment, to decide on treatment. On day 2-3 of the cycle, measures including basic ultrasound and initial tests are requested and then 21 units of subcutaneous ampoules of Cinnafact are prescribed daily for 0.5 units, and they are taught how to use infertility drugs and the time of their next visit. Second, HMG 150-300 units are added daily depending on the ovarian reserve under the supervision of an infertility specialist and 6 days after the onset of ovarian stimulation, folliculography is performed every two to three days, until at least 3 dominant 17 mm follicles are observed. HCG is triggered and ovulation will occur 36 hours later.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Stress score. Timepoint: The beginning of the study (before the intervention) and the trigger day (two weeks after the last consultation) and two weeks after the embryo transfer. Method of measurement: Newton Infertility Stress Questionnaires.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Follicle number. Timepoint: Number of ovarian follicles at trigger time with HCG. Method of measurement: With ultrasound by a gynecologist.</sec_outcome>
      <sec_outcome>Pregnancy rates. Timepoint: Two weeks after embryo transfer. Method of measurement: blood test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-06-15</approval_date>
        <contact_name>Ethics committee Mashhad University of Medical Sciences and Health Services</contact_name>
        <contact_address>Opposite to University Street 18, University Street, Mashhad University of Medical Sciences, Khorasan Razavi, Iran Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
